Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VELCADE in Previously Treated Bronchioloalveolar Carcinoma
NCT00117351Phase 2Terminated
- Sponsor
- Millennium Pharmaceuticals
- Start
- Apr 2005
- Primary completion
- Jun 2007
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in bronchioloalveolar carcinoma (BAC), Adenocarcinoma, sponsored by Millennium Pharmaceuticals. Started Apr 2005; status: terminated.
02
Drugs
bortezomib
03
Conditions
bronchioloalveolar carcinoma (BAC)Adenocarcinoma
Beyond the preview
Go deeper on NCT00117351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00117351.